The company's second spin-out in 2010 from its partnership with the university, Progenteq, is developing a technology that may just revolutionise cartillage replacement therapy.
Only registred members can create thier own customized alerts.
08/02/10
The company's second spin-out in 2010 from its partnership with the university, Progenteq, is developing a technology that may just revolutionise cartillage replacement therapy.
09/11/09
IP Group will now hold a 19.8% stake in the company and will have the right to acquire 20% of Fusion’s shareholding in any portfolio company for £0.5 million in cash.
16/02/09
Fusion IP specialises in the commercialisation of university-developed intellectual property, turning research into business via a growing portfolio of companies.